Target intelligence / Profile preview

Insulin growth factor-like family member 3 (IGFL3)

Target
IGFL3
Molecular classification
Other (member of the insulin-like growth factor-like family; not a receptor, enzyme, or transporter but a secreted signaling molecule)
01

Overview

Insulin growth factor-like family member 3 (IGFL3) is a small secreted protein consisting of 125 amino acids, encoded by the IGFL3 gene in humans[2][7]. It is a member of the insulin-like growth factor (IGF) superfamily, which includes several growth factor signaling proteins important for cellular energy metabolism and development[4]. IGFL3 is evolutionarily conserved and primarily found in vertebrates, but its precise physiological function remains unclear and is currently subject to investigation. No experimental evidence has been documented for direct involvement in signal transduction, disease processes, or therapeutic targeting in humans to date[6][7]. Although categorized within a superfamily containing critical hormones, IGFL3 itself has no established role as a therapeutic target, nor are there any reported drug interactions, biomarker applications, or notable safety concerns[7]. It is generally referenced as a potential signaling molecule due to sequence homology with IGF family members, but biological data remain sparse. **Summary of key points:** - The most accurate, recognized name is "Insulin growth factor-like family member 3" (IGFL3)[2][7]. - Abundant alternative names and identifiers exist, but none describe a receptor, enzyme, transporter, or major druggable protein class. - As of current knowledge, IGFL3 is *not* a validated or widely investigated drug target, and has minimal disease association. - It should not be confused with IGFBP-3 (Insulin-like growth factor-binding protein 3), a distinct, well-studied IGF pathway protein involved in cancer and metabolism, which is a separate molecule entirely[1][3][5].

Other names
IGFL3IGF-like family member 3UNQ483/PRO982UNQ483RPRC483
02

Biological functions

Potential signaling molecule, presumed to play roles in energy metabolism and developmentExact biological function is not clearly characterized in the literature for humans[4][6][7]
03

Disease associations

Other (weak disease association only; has been weakly linked with testicular disease and cryptorchidism in genetic association databases, but no established therapeutic relevance as of this time)[7]

Beyond the preview

Go deeper on Insulin growth factor-like family member 3 (IGFL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin growth factor-like family member 3 (IGFL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call